在早期临床开发中使用0期和微型追踪器方法:过去,现在和未来
A F Roffel1, E-J van Hoogdalem1
1ICON plc, Groningen, Netherlands.
Frontiers in pharmacology
|April 2, 2024
概括
第0阶段的微剂量研究,定义为亚药理学剂量,在药物开发中得到了有限的采用. 本综述审查了它们过去的使用情况,并提出了提高在早期临床试验中微剂量使用的策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物开发 药物开发
- 临床试验 临床试验
背景情况:
- 第0阶段的微剂量研究是在20年前引入的,用于早期药物开发.
- 微剂量是药理学上活跃的人类剂量的1/100以下 (蛋白质最大100μg或30nmoles).
- 工业界对0期研究的采用是有限的,随着时间的推移,参与率下降.
研究的目的:
- 审查早期临床开发中0期微剂量设计的历史应用和经验.
- 评估静脉注射 (IV) 的功用. 微剂量绝对生物可用性 (ABA) 研究.
- 确定必要的因素,以增加0期/微剂量研究的采用.
主要方法:
- 对0期微剂量研究历史数据的审查.
- 静脉注射14C微剂量绝对生物可用性 (ABA) 研究应用的分析.
- 评估行业趋势和微剂量采用的潜在障碍.
主要成果:
- 第0阶段研究的数量略有下降,平均每年1.4-2.
- 静脉微剂量ABA研究,虽然不是正式的第0期,但经常使用 (例如. 每年有2个).
- 这些ABA研究代表了微剂量原则的最常见和最有信息的应用.
结论:
- 尽管有潜力,但0期微剂量研究尚未被制药行业完全接受.
- 静脉微剂量ABA研究是一个有价值的,广泛使用的应用程序,突出了微剂量概念的实用性.
- 需要进一步的战略来促进更广泛的采用,并最大限度地利用药物开发中的0期/微剂量研究的好处.
更多相关视频
09:55Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
Published on: October 4, 2024
367
07:45Author Spotlight: Standardizing Mouse In Vivo PET Imaging with Body Conforming Molds and Automated Analysis
Published on: October 25, 2024
374
相关概念视频
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
